1. Home
  2. WYHG vs PVLA Comparison

WYHG vs PVLA Comparison

Compare WYHG & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WYHG
  • PVLA
  • Stock Information
  • Founded
  • WYHG 1915
  • PVLA 2015
  • Country
  • WYHG China
  • PVLA United States
  • Employees
  • WYHG 491
  • PVLA N/A
  • Industry
  • WYHG
  • PVLA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WYHG
  • PVLA Health Care
  • Exchange
  • WYHG NYSE
  • PVLA Nasdaq
  • Market Cap
  • WYHG 261.7M
  • PVLA 308.2M
  • IPO Year
  • WYHG 2024
  • PVLA N/A
  • Fundamental
  • Price
  • WYHG $9.13
  • PVLA $26.68
  • Analyst Decision
  • WYHG
  • PVLA Strong Buy
  • Analyst Count
  • WYHG 0
  • PVLA 6
  • Target Price
  • WYHG N/A
  • PVLA $43.50
  • AVG Volume (30 Days)
  • WYHG 353.7K
  • PVLA 94.6K
  • Earning Date
  • WYHG 01-01-0001
  • PVLA 05-15-2025
  • Dividend Yield
  • WYHG N/A
  • PVLA N/A
  • EPS Growth
  • WYHG 10.09
  • PVLA N/A
  • EPS
  • WYHG 0.27
  • PVLA N/A
  • Revenue
  • WYHG $144,231,605.00
  • PVLA N/A
  • Revenue This Year
  • WYHG N/A
  • PVLA N/A
  • Revenue Next Year
  • WYHG N/A
  • PVLA N/A
  • P/E Ratio
  • WYHG $5.05
  • PVLA N/A
  • Revenue Growth
  • WYHG 9.73
  • PVLA N/A
  • 52 Week Low
  • WYHG $3.55
  • PVLA $6.20
  • 52 Week High
  • WYHG $5.35
  • PVLA $29.27
  • Technical
  • Relative Strength Index (RSI)
  • WYHG N/A
  • PVLA N/A
  • Support Level
  • WYHG N/A
  • PVLA N/A
  • Resistance Level
  • WYHG N/A
  • PVLA N/A
  • Average True Range (ATR)
  • WYHG 0.00
  • PVLA 0.00
  • MACD
  • WYHG 0.00
  • PVLA 0.00
  • Stochastic Oscillator
  • WYHG 0.00
  • PVLA 0.00

About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD

Wing Yip Food Holdings Group Ltd is a meat producer. The company is mainly engaged in offering ready to eat and packaged meat dishes. Its product offerings include supreme crispy sausage, fully thin sausage, Chinese sausage, Dongguan Erba sausage, yellow scorpion sausage, alcohol sausage, and meat chop.

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.

Share on Social Networks: